Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2005
08/17/2005EP1562958A1 N-sulfonylaminothiazole
08/17/2005EP1562945A1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
08/17/2005EP1562943A1 Fused heterocyclic compounds
08/17/2005EP1562938A1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562932A1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562922A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
08/17/2005EP1562919A1 Phenylalkyl and pyridylalkyl piperazine derivatives
08/17/2005EP1562918A1 Substituted benzoxazinones and uses thereof
08/17/2005EP1562917A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
08/17/2005EP1562625A2 Pain relief agents
08/17/2005EP1562588A2 Use of pde4 inhibitors as adjunct therapy for psychiatric disorders
08/17/2005EP1562586A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
08/17/2005EP1562582A1 Cholesterol absorption inhibitors for the treatment of demyelination
08/17/2005EP1562581A2 Pharmaceutical composition comprising cannabinoids for the treatment of pain andsleep disorders
08/17/2005EP1562579A1 Therapeutic delivery of carbon monoxide
08/17/2005EP1562577A1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents
08/17/2005EP1562576A1 Enhancement of alcohol metabolism
08/17/2005EP1562575A1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy
08/17/2005EP1562572A2 Pharmaceutical solutions of modafinil compounds
08/17/2005EP1562570A1 Treatment of amyotrophic lateral sclerosis with nimesulide
08/17/2005EP1562560A1 Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
08/17/2005EP1463725B1 Process and intermediates for pyridazinone antidiabetic agents
08/17/2005EP1429617A4 Methods for sterilizing preparations of digestive enzymes
08/17/2005EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
08/17/2005EP1311256B1 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
08/17/2005EP1289520B1 Pharmaceutical compositions for the treatment of depression comprising famotidine
08/17/2005EP1253853A4 Method for classifying and treating physiologic brain imbalances using quantitative eeg
08/17/2005EP1248643B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
08/17/2005EP1237552B1 Combination of lumilysergol and riluzole for preventing and/or treating motoneuronal diseases
08/17/2005EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
08/17/2005EP1185268B1 The therapeutic use of d-threo-methylphenidate for the treatment of attention-deficit hyperactivity disorder
08/17/2005EP1154776B1 Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005EP1087775B1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
08/17/2005EP1073723B1 Ste20-related protein kinases
08/17/2005EP1023445B1 Cadherin derived growth factor and the application thereof
08/17/2005EP1023067B9 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005EP0835128B1 Use of il-11 to treat inflammation
08/17/2005EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/17/2005CN1656119A Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
08/17/2005CN1656113A Sialic combined immunoglobulin like agglutinin inhibitors
08/17/2005CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656098A Fused bicyclic pyrimidine derivatives
08/17/2005CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
08/17/2005CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
08/17/2005CN1656093A 3-substituted quinuclidines and their use
08/17/2005CN1656089A Phenyl-thiophene type vitamin D receptor modulators
08/17/2005CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656084A Hydroxymorpholinone derivative and medicinal use thereof
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656078A Aminoindazole derivatives as protein kinase inhibitor
08/17/2005CN1656075A Quinoline derivatives and their use as 5-HT6 ligands
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656070A Melanocortin receptor ligands
08/17/2005CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
08/17/2005CN1656067A New salts
08/17/2005CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin
08/17/2005CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
08/17/2005CN1655848A Use of new etonogestrel esters
08/17/2005CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
08/17/2005CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
08/17/2005CN1655809A Compositions and methods for treating and preventing necrosis
08/17/2005CN1655806A Treatment of diseases involving defective gap junctional communication
08/17/2005CN1655803A Methods of improving central nervous system functioning
08/17/2005CN1655793A A combination of an NMDA-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
08/17/2005CN1655789A New pharmaceutical compositions containing flibanserin polymorph A
08/17/2005CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655784A Use of compounds that are effective as selective opiate receptor modulators
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1655770A Chewable soft capsule
08/17/2005CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
08/17/2005CN1655762A Ibuprofen suspension
08/17/2005CN1655761A Modified release pharmaceutical formulation
08/17/2005CN1655692A Alertness bar
08/17/2005CN1655675A Combination therapy using trefoil peptides
08/17/2005CN1654657A Novel streptococcus antigens
08/17/2005CN1654052A Chinese medicinal tonifying wine with kidney warming, yang activating, cold dispersing, pain relieving, blood activating, qi circulation promoting functions
08/17/2005CN1654048A Chinese medicinal tonifying wine112
08/17/2005CN1215080C Substd. sapogenins and their use
08/17/2005CN1214811C Traditional Chinese medicine for treating neurosism, extracting process, formation process and use thereof
08/17/2005CN1214799C Medicine for treating sciatic nerve diseases
08/17/2005CN1214794C Use of prostaglandin A1 in treatment of nerve degenerative diseases such as cerebral ischemia apoplexy
08/17/2005CN1214793C Central nerve antalgic preparation through nasal cavity administration
08/17/2005CN1214790C Method for preparing isoxazole substituted composition for treating inflammation
1 ... 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 ... 1833